Chapter 34 — Further Reading

Textbooks

• Vance, D. E., and Vance, J. E. (eds.) (2008). Biochemistry of Lipids, Lipoproteins, and Membranes, 5th ed. (Elsevier). The standard lipid biochemistry reference.

• Lehninger / Nelson and Cox. Principles of Biochemistry, 7th or later ed. (W. H. Freeman). Chapters 10 (lipids), 17 (fatty acid catabolism), 21 (lipid biosynthesis).

• Berg, J. M., et al. Biochemistry, 9th or later ed. (W. H. Freeman). Excellent treatment of fatty acid metabolism and cholesterol biosynthesis.

• Voet, D., and Voet, J. G. Biochemistry, 4th ed. (Wiley, 2010). Comprehensive coverage of lipid biochemistry.

• Dewick, P. M. (2009). Medicinal Natural Products: A Biosynthetic Approach, 3rd ed. (Wiley). Excellent treatment of terpene biosynthesis.

• Christie, W. W., and Han, X. (2010). Lipid Analysis, 4th ed. (Oily Press). Reference for analytical methods.

Primary literature: terpene biosynthesis

• Ruzicka, L. (1953). "The isoprene rule and the biogenesis of terpenic compounds." Experientia 9, 357–367. Ruzicka's Nobel Lecture (Nobel 1939) on the isoprene rule.

• Lynen, F. (1959). "Steps in the formation of mevalonic acid." Federation Proceedings 18, 1057–1067. Lynen's discovery of HMG-CoA and its reduction to mevalonate. Lynen Nobel 1964.

• Bloch, K. (1965). "The biological synthesis of cholesterol." Science 150(3692), 19–28. Konrad Bloch's Nobel Lecture (1964) on cholesterol biosynthesis.

• Cornforth, J. W. (1969). "Cholesterol biosynthesis: from squalene." Annual Review of Biochemistry 38, 287–300. Cornforth's pioneering work on the stereochemistry of squalene cyclization. Nobel 1975.

• Eschenmoser, A., et al. (1955). The first proposal for squalene cyclization to lanosterol — the polyene cyclization mechanism. Helvetica Chimica Acta.

Primary literature: statins and cholesterol drugs

• Endo, A., Kuroda, M., and Tsujita, Y. (1976). "ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum." Journal of Antibiotics 29(12), 1346–1348. The discovery of the first statin.

• Endo, A. (1992). "The discovery and development of HMG-CoA reductase inhibitors." Journal of Lipid Research 33(11), 1569–1582. Endo's review of statin discovery.

• Goldstein, J. L., and Brown, M. S. (1973). The discovery of the LDL receptor and the genetic basis of familial hypercholesterolemia. Annual Review of Biochemistry 42, 207. Brown and Goldstein Nobel 1985.

• Liscum, L., et al. (1985). 3-Hydroxy-3-methylglutaryl-CoA reductase: a transmembrane glycoprotein of the endoplasmic reticulum with N-linked "high-mannose" oligosaccharides. Proceedings of the National Academy of Sciences USA 80, 7165–7169. Structural studies on HMG-CoA reductase.

Primary literature: prostaglandins, eicosanoids

• Vane, J. R. (1971). "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs." Nature New Biology 231, 232–235. Vane's Nobel-winning discovery of how aspirin works. Nobel 1982.

• Bergström, S., Samuelsson, B., et al. (1962-1980s). Series of papers on prostaglandin chemistry and biology. Bergström and Samuelsson Nobel 1982.

Primary literature: rubber and polymer chemistry

• Goodyear, C. (1844). U.S. Patent 3,633: vulcanization of rubber. Vulcanized rubber was patented by Goodyear in 1844 — a discovery that transformed industrial materials.

• Ziegler, K., and Natta, G. (1955-1960s). Series of papers on stereoselective polymerization. Ziegler and Natta Nobel 1963 for catalysts that enable stereocontrolled polymer synthesis.

Industrial chemistry references

• Weissermel, K., and Arpe, H.-J. (2003). Industrial Organic Chemistry, 4th ed. (Wiley-VCH). Chapter on fatty acids, oils, and lipid industries.

• Rajanna, K. C. (2010). Aliphatic Carboxylic Acids and Derivatives. Chapter on industrial fatty acid chemistry.

• Mortier, J. (1976). Rubber: A Review. Industrial perspective on rubber chemistry and engineering.

Computational tools and references

• Avogadro (https://avogadro.cc/). Build squalene, lanosterol, cholesterol; visualize the polyene cyclization geometry.

• PubChem — look up: palmitic acid (CID 985), oleic acid (CID 445639), cholesterol (CID 5997), squalene (CID 638072), atorvastatin (CID 60823), simvastatin (CID 54454).

• KEGG (Kyoto Encyclopedia of Genes and Genomes) (https://www.kegg.jp/): pathway database for fatty acid biosynthesis, β-oxidation, and cholesterol biosynthesis.

• Reaxys for synthesis literature.

Online resources

• Master Organic Chemistry, "Lipids" series. Free undergraduate-level explanations.

• Khan Academy: Biology — Lipids and Membranes. Free videos.

• HMDB (Human Metabolome Database) (https://hmdb.ca/). Includes structures, properties, and metabolic information for human lipids.

For practice problems

• Klein, David. Organic Chemistry as a Second Language, 4th ed. (Wiley). Chapter on lipids.

• Karty, Joel. Organic Chemistry: Principles and Mechanisms, 2nd ed. (W. W. Norton, 2018). Chapter on lipid chemistry.

• Sorrell, Thomas N. Organic Chemistry, 2nd ed. (University Science Books, 2006). Chapter on lipid chemistry.

Mathematically inclined readers

• van Wijk, R., et al. (multiple papers). Computational modeling of squalene cyclization with quantum chemistry methods.

• Davidson, V. L. (2007). Various papers on enzymatic stereochemistry of polyene cyclization.

Notes on this chapter's pedagogy

Chapter 34 applies Chapter 28 chemistry (Claisen condensations) to lipid biosynthesis. The key insight: all lipids are biosynthesized from acetyl-CoA via iterated mechanisms. Fatty acids: linear iteration. Terpenes: branched iteration via mevalonate and IPP. Cholesterol: terpenoid + cyclization + modifications.

This is the deepest payoff of mechanism-first pedagogy. A few mechanisms (Claisen, reduction, cyclization) generate enormous structural diversity. Master the few mechanisms, and you understand a vast class of products.

The chapter ends with industrial connections (statins, rubber, vitamins) showing why lipid chemistry matters beyond pure biology. Chapter 35 will turn to drug design as the application of all this chemistry to medicine.